This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Sens. Amy Klobuchar, D-Minn., and Roger Marshall, MD, R-Kan., introduced the companion version of the Find It Early Act over a year after the House bill was proposed.
As the U.S. celebrates this year's Breast Cancer Awareness Month, radiology experts and advocates reflect on the big year that breast imaging has had. From the U.S. Food and Drug Administration’s (FDA’s) mandate on breast density notification taking effect to state- and federal-level legislation being introduced and passed for insurance coverage on supplemental imaging, breast imaging is poised to experience transformation soon, the experts said.
After reviewing years' worth of data from their clinic, one institution discovered that on numerous occasions issues with implant data integrity put patients at risk.
Three of the seven Medicare Administrative Contractors have now agreed to cover cerebral perfusion analysis, used to assess for signs and symptoms of a stroke.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Few radiology subspecialties can match mammography at adopting new imaging modalities to improve patient care. Consider: The past 10 to 15 years have seen the rise of digital breast tomosynthesis, automated breast ultrasound, breast MRI (with and without diffusion weighting), low-dose positron emission mammography and contrast-enhanced dual-energy digital mammography.
Few radiology subspecialties can match mammography at adopting new imaging modalities to improve patient care. Consider: The past 10 to 15 years have seen the rise of digital breast tomosynthesis, automated breast ultrasound, breast MRI (with and without diffusion weighting), low-dose positron emission mammography and contrast-enhanced dual-energy digital mammography.
Breast surgical oncologist Lauren Ramsey, MD, of John Peter Smith Hospital in Fort Worth, TX, has developed a new protection garment for radiologic technologists that mitigates radiation exposure while they are imaging patients. Called BAT (Breast, Axilla, and Thyroid), the garment features a 0.35 mm Xenolite 800 NLE layer in the main body, sleeves, and breastplate.
Seventeen years was all it took for flurpiridaz F-18 to reach the market – the first patient was injected with the PET imaging agent in November 2007, by Jamshid Maddahi, MD, and colleagues, of the University of California, Los Angeles. Today, the radiotracer is poised to help expand the use of cardiac PET imaging on a national scale and ultimately improve care for people with coronary artery disease (CAD).
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
IBC Advanced Technologies is launching its subsidiary, RadSep, which will be dedicated to radiochemical separation technology for the radiopharmaceutical industry. RadSep's proprietary Molecular Recognition Technology (MRT) introduces an approach to separating upstream radioisotopes used in the production of feedstocks, as well as downstream radioisotopes used directly in the manufacture of drug products for radioligand therapies.
A new study has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer.
Royal Philips is highlighting greenhouse gas (GHG) emissions reduction results following collaboration with customers to assess and mitigate their carbon footprints while also improving patient care and operational efficiency. The company noted the following achievements from hospital systems in the U.S. and Europe: Jackson Health System (Miami, FL, U.S.): A 47% projected reduction in carbon dioxide (CO2) emissions by replacing legacy patient monitors, comprising 508-tons equipment lifecycle CO2
Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,00 women with no prior history of breast cancer.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
X-ray detector developer Detection Technology is establishing a service and production facility in Delhi, India. The facility will improve the customer experience by offering local service, faster response and delivery times, and cost-effective strategies, the company said. It plans to ship "Made in India" products starting in early 2025. Company leaders noted that the initial focus will be on the end-assembly and final testing of detector boards optimized for security x-ray imaging applications
A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer.
AI scoring could help predict future breast cancer risk and identify high-risk women, suggest findings published October 3 in JAMA Network Open. Researchers led by Solveig Hofvind, PhD, from the Norwegian Institute of Public Health in Oslo found that absolute average AI scores based on commercially available algorithms were higher for breasts developing cancer versus not developing cancer four to six years before their eventual detection on screening mammography.
tim.hodson Thu, 10/03/2024 - 11:53 Sept. 30, 2024 – A recent study accepted by the American Society of Radiation Oncology (ASTRO) for their annual meeting in Washington D.C. demonstrates a significant reduction in radiation Planning Target Volume involving patients who received Breast Conserving Surgery (lumpectomy), a VeraForm marker for cavity delineation and Accelerated Partial Breast Irradiation (APBI) along with Deep Inspiration Breath Hold (DIBH) for motion management.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The regulations in 21 CFR Part 212 ensure PET drugs are manufactured under strict quality control and safety standards. The post Ensuring Quality and Compliance: A Guide to 21 CFR Part 212 for PET Drug Manufacturing appeared first on Open MedScience.
tim.hodson Thu, 10/03/2024 - 12:10 October 2, 2024 – Owkin recently announce a new partnership with AstraZeneca to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides. As part of Owkin’s ongoing collaboration with Gustave Roussy and The Centre Léon Bérard through PortrAIt, a French consortium to accelerate precision medicine through AI-enabled digital pathology, this tool aims to significantly accelerate and expand acce
First completely redesigned Siemens Healthineers mammography platform in over a decade PMA includes new 3D image acquisition and reconstruction technology New features focus on patient comfort and user ergonomics Siemens Healthineers announces the Food and Drug Administration’s premarket approval for the tomosynthesis or three-dimensional breast imaging technology of the MAMMOMAT B.brilliant—the first completely redesigned Siemens Healthineers mammography platform in over a decade.
A new handheld scanner can generate highly detailed 3D photoacoustic images in just seconds, paving the way for the use of photoacoustic tomography imaging in clinical settings for the first time and allowing earlier disease diagnosis.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Common Indications Hallux Valgus Assess rotation (pronation) of the 1st metatarsal. Assess the position of the sesamoids and degenerative changes at the metatarsosesamoid joints. Assess congruency and degenerative changes at the 1st MTP joint. Midfoot Arthritis Provide a clearer assessment of degenerative changes and joint space narrowing within the midfoot joints, which is normally impaired due to the natural overlap of adjacent midfoot bones viewed two-dimensionally with conventional radiograp
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content